Education and Health Notices




22 NOVEMBER

NEW ZEALAND GAZETTE

3881

  • To develop within the tamariki pride in who they are.
  • Nurture and safeguard the mauri, mana and wairua of
    our tamariki, mokopuna and cater for the spiritual
    development of the child.
  • To honour the Treaty of Waitangi.
  • To have a school where the tamariki are the most
    important component.
  • To raise the academic achievement, self-esteem,
    self-confidence, pride and mana of Ngai Tai tamariki
    by integrating positive Māori values and principles into
    every aspect of the school activities.

Constitution of the Board of Trustees

  1. The Board of Trustees of Te Kura o Torere shall
    comprise:

(a) Five people appointed by the Minister.
(b) The principal or principal designate.
(c) Not more than 4 persons co-opted by the board.

Dated at Wellington this 15th day of November 2001.

TREVOR MALLARD, Minister of Education.

go8259

Private Schools Conditional Integration

Act 1975

Supplementary Integration Agreement

Pursuant to section 10 of the Private Schools Conditional
Integration Act 1975, notice is given that a supplementary
integration agreement has been signed between the Minister
of Education on behalf of Her Majesty the Queen, acting
through the Senior Manager, National Operations, Ministry
of Education, pursuant to delegated authority, and the
proprietor of the following school:

Hillview Christian School, Christchurch.

The said supplementary integration agreement was executed
on 16 November 2001.

A copy of the supplementary integration agreement is
available for inspection without charge by any member of
the public at the regional office of the Ministry of
Education, 123 Victoria Street, Christchurch.

Dated at Wellington this 16th day of November 2001.

KATHY PHILLIPS, Senior Manager, National Operations.

go8194

Health

Medicines Act 1981

Consent to the Distribution of Changed Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of
the changed medicines that were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set
out in the Schedule hereto:

Schedule

Product: Emla
Active Ingredient(s): Lignocaine 2.5%w/w
Prilocaine 2.5%w/w
Dosage Form: Topical cream
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Södertälje, Sweden
Product: Eprex
Active Ingredient(s): Epoetin alfa 84µg/mL
Dosage Form: Solution for injection
New Zealand Sponsor: Janssen-Cilag Pty Limited
Manufacturer(s): Cilag AG, Schaffhausen, Switzerland
Janssen Pharmaceutica NV, Beerse, Belgium
Vetter Pharma-Fertigung GmbH & Co Kg, Ravensburg, Germany
Product: Rapamune
Active Ingredient(s): Sirolimus 1mg/mL
Dosage Form: Oral solution
New Zealand Sponsor: Wyeth (NZ) Limited
Manufacturer(s): Ayerst Laboratories, Division of Wyeth-Ayerst Pharmaceuticals Inc, Rouses Point, New York,
United States of America

Note: This product has provisional consent that expires on 11 January 2003.

Dated this 15th day of November 2001.

G. R. BOYD, Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the 20th day of
February 1997).

go8138



Next Page →



Online Sources for this page:

VUW Te Waharoa PDF NZ Gazette 2001, No 159


Gazette.govt.nz PDF NZ Gazette 2001, No 159





✨ LLM interpretation of page content

🎓 Te Kura o Torere Establishment (continued from previous page)

🎓 Education, Culture & Science
15 November 2001
Education Act 1989, School Establishment, Te Kura o Torere, Designated Character School
  • TREVOR MALLARD, Minister of Education

🎓 Supplementary Integration Agreement for Hillview Christian School

🎓 Education, Culture & Science
16 November 2001
Private Schools Conditional Integration Act 1975, Supplementary Integration Agreement, Hillview Christian School, Christchurch
  • KATHY PHILLIPS, Senior Manager, National Operations

🏥 Consent to the Distribution of Changed Medicines

🏥 Health & Social Welfare
15 November 2001
Medicines Act 1981, Consent, Distribution, Changed Medicines, Emla, Eprex, Rapamune
  • G. R. BOYD, Chief Advisor, Safety and Regulation